BRIEF-Landbridge Co To Buy 37,500 Acres In Texas For $250 Million - SEC Filing-February 2024-www.financetom.com

BRIEF-Landbridge Co To Buy 37,500 Acres In Texas For $250 Million - SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Landbridge Co To Buy 37,500 Acres In Texas For $250 Million - SEC Filing

Oct 7, 2025 6:27 AM

Oct 7 (Reuters) - LandBridge Co LLC ( LB ):

* LANDBRIDGE CO LLC ( LB ) - TO BUY 37,500 ACRES IN TEXAS FOR $250

MILLION - SEC FILING

* LANDBRIDGE CO LLC ( LB ) - ON OCT 3, DBR LAND ENTERED THIRD

AMENDMENT

TO CREDIT AGREEMENT - SEC FILING

* LANDBRIDGE CO LLC ( LB ) - AMENDMENT INCLUDES $200 MILLION

DELAYED DRAW

TERM LOAN FACILITY - SEC FILING

Further company coverage:

Previous page： --Amazon.com Guides For Q3 Sales of $154-$158.5 Billion, vs CIQ Analyst Consensus of $158.3 Billion Next page： Intel to cut 15% jobs, suspend dividend in turnaround push

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--Amazon.com Guides For Q3 Sales of $154-$158.5 Billion, vs CIQ Analyst Consensus of $158.3 Billion

Aug 1, 2024

04:02 PM EDT, 08/01/2024 (MT Newswires) -- Price: 175.08, Change: -8.99, Percent Change: -4.88 ...

Intel to cut 15% jobs, suspend dividend in turnaround push

Aug 1, 2024

-Intel ( INTC ) said on Thursday it would cut 15% of its workforce and will suspend its dividend in the fourth quarter as the chipmaker pursues a turnaround centered around its loss-making manufacturing business. Shares of the Santa Clara, California-based company fell 10% in extended trading. The stock closed down 7% on Thursday, in tandem with U.S. chip stocks...

--Intel Guides For Q3 Loss of $0.03 Per Share on Revenue of $12.5-$13.5 Billion, vs CIQ Analyst Consensus of $0.31/Share Profit on Revenue of $14.4 Billion

Aug 1, 2024

04:03 PM EDT, 08/01/2024 (MT Newswires) -- Price: 26.00, Change: -3.05, Percent Change: -10.50 ...

Vertex Pharma raises annual revenue forecast on strong demand for its cystic fibrosis treatments

Aug 1, 2024

Aug 1 (Reuters) - Vertex Pharmaceuticals ( VRTX ) raised its annual revenue forecast on Thursday, betting on robust demand for its cystic fibrosis (CF) treatments. The drugmaker now expects 2024 product revenue in the range of $10.65 to $10.85 billion, compared to its prior forecast of $10.55 to $10.75 billion. The company said that the forecast includes expectations for...